255 related articles for article (PubMed ID: 31417080)
1. Interplay of protein corona and immune cells controls blood residency of liposomes.
Giulimondi F; Digiacomo L; Pozzi D; Palchetti S; Vulpis E; Capriotti AL; Chiozzi RZ; Laganà A; Amenitsch H; Masuelli L; Peruzzi G; Mahmoudi M; Screpanti I; Zingoni A; Caracciolo G
Nat Commun; 2019 Aug; 10(1):3686. PubMed ID: 31417080
[TBL] [Abstract][Full Text] [Related]
2. Effects of the protein corona on liposome-liposome and liposome-cell interactions.
Corbo C; Molinaro R; Taraballi F; Toledano Furman NE; Sherman MB; Parodi A; Salvatore F; Tasciotti E
Int J Nanomedicine; 2016; 11():3049-63. PubMed ID: 27445473
[TBL] [Abstract][Full Text] [Related]
3. A novel scavenging tool for cancer biomarker discovery based on the blood-circulating nanoparticle protein corona.
Hadjidemetriou M; Al-Ahmady Z; Buggio M; Swift J; Kostarelos K
Biomaterials; 2019 Jan; 188():118-129. PubMed ID: 30343255
[TBL] [Abstract][Full Text] [Related]
4. Opsonin-Deficient Nucleoproteic Corona Endows UnPEGylated Liposomes with Stealth Properties
Giulimondi F; Vulpis E; Digiacomo L; Giuli MV; Mancusi A; Capriotti AL; Laganà A; Cerrato A; Zenezini Chiozzi R; Nicoletti C; Amenitsch H; Cardarelli F; Masuelli L; Bei R; Screpanti I; Pozzi D; Zingoni A; Checquolo S; Caracciolo G
ACS Nano; 2022 Feb; 16(2):2088-2100. PubMed ID: 35040637
[TBL] [Abstract][Full Text] [Related]
5. Unveiling the in Vivo Protein Corona of Circulating Leukocyte-like Carriers.
Corbo C; Molinaro R; Taraballi F; Toledano Furman NE; Hartman KA; Sherman MB; De Rosa E; Kirui DK; Salvatore F; Tasciotti E
ACS Nano; 2017 Mar; 11(3):3262-3273. PubMed ID: 28264157
[TBL] [Abstract][Full Text] [Related]
6. Tuning liposome composition to modulate corona formation in human serum and cellular uptake.
Yang K; Mesquita B; Horvatovich P; Salvati A
Acta Biomater; 2020 Apr; 106():314-327. PubMed ID: 32081780
[TBL] [Abstract][Full Text] [Related]
7. The protein corona of circulating PEGylated liposomes.
Palchetti S; Colapicchioni V; Digiacomo L; Caracciolo G; Pozzi D; Capriotti AL; La Barbera G; Laganà A
Biochim Biophys Acta; 2016 Feb; 1858(2):189-96. PubMed ID: 26607013
[TBL] [Abstract][Full Text] [Related]
8. In Vivo Biomolecule Corona around Blood-Circulating, Clinically Used and Antibody-Targeted Lipid Bilayer Nanoscale Vesicles.
Hadjidemetriou M; Al-Ahmady Z; Mazza M; Collins RF; Dawson K; Kostarelos K
ACS Nano; 2015 Aug; 9(8):8142-56. PubMed ID: 26135229
[TBL] [Abstract][Full Text] [Related]
9. Human Biomolecular Corona of Liposomal Doxorubicin: The Overlooked Factor in Anticancer Drug Delivery.
Caracciolo G; Palchetti S; Digiacomo L; Chiozzi RZZ; Capriotti AL; Amenitsch H; Tentori PM; Palmieri V; Papi M; Cardarelli F; Pozzi D; Laganà A
ACS Appl Mater Interfaces; 2018 Jul; 10(27):22951-22962. PubMed ID: 29905462
[TBL] [Abstract][Full Text] [Related]
10. The biomolecular corona of nanoparticles in circulating biological media.
Pozzi D; Caracciolo G; Digiacomo L; Colapicchioni V; Palchetti S; Capriotti AL; Cavaliere C; Zenezini Chiozzi R; Puglisi A; Laganà A
Nanoscale; 2015 Sep; 7(33):13958-66. PubMed ID: 26222625
[TBL] [Abstract][Full Text] [Related]
11. How Corona Formation Impacts Nanomaterials as Drug Carriers.
Gupta MN; Roy I
Mol Pharm; 2020 Mar; 17(3):725-737. PubMed ID: 31939673
[TBL] [Abstract][Full Text] [Related]
12. Revealing the immune perturbation of black phosphorus nanomaterials to macrophages by understanding the protein corona.
Mo J; Xie Q; Wei W; Zhao J
Nat Commun; 2018 Jun; 9(1):2480. PubMed ID: 29946125
[TBL] [Abstract][Full Text] [Related]
13. Effect of Glucose on Liposome-Plasma Protein Interactions: Relevance for the Physiological Response of Clinically Approved Liposomal Formulations.
Palchetti S; Digiacomo L; Pozzi D; Zenezini Chiozzi R; Capriotti AL; Laganà A; Coppola R; Caputo D; Sharifzadeh M; Mahmoudi M; Caracciolo G
Adv Biosyst; 2019 Feb; 3(2):e1800221. PubMed ID: 32627369
[TBL] [Abstract][Full Text] [Related]
14. Influence of protein corona on the interaction of glycogen-siRNA constructs with ex vivo human blood immune cells.
Wojnilowicz M; Laznickova P; Ju Y; Ang CS; Tidu F; Bendickova K; Forte G; Plebanski M; Caruso F; Cavalieri F; Fric J
Biomater Adv; 2022 Sep; 140():213083. PubMed ID: 36027666
[TBL] [Abstract][Full Text] [Related]
15. Spotlight on the protein corona of liposomes.
Onishchenko N; Tretiakova D; Vodovozova E
Acta Biomater; 2021 Oct; 134():57-78. PubMed ID: 34364016
[TBL] [Abstract][Full Text] [Related]
16. An in vitro assay based on surface plasmon resonance to predict the in vivo circulation kinetics of liposomes.
Crielaard BJ; Yousefi A; Schillemans JP; Vermehren C; Buyens K; Braeckmans K; Lammers T; Storm G
J Control Release; 2011 Dec; 156(3):307-14. PubMed ID: 21803084
[TBL] [Abstract][Full Text] [Related]
17. Amphiphilic dendrimers control protein binding and corona formation on liposome nanocarriers.
Wagner J; Dillenburger M; Simon J; Oberländer J; Landfester K; Mailänder V; Ng DYW; Müllen K; Weil T
Chem Commun (Camb); 2020 Aug; 56(61):8663-8666. PubMed ID: 32608398
[TBL] [Abstract][Full Text] [Related]
18. Liposome protein corona characterization as a new approach in nanomedicine.
Capriotti AL; Cavaliere C; Piovesana S
Anal Bioanal Chem; 2019 Jul; 411(19):4313-4326. PubMed ID: 30758528
[TBL] [Abstract][Full Text] [Related]
19. Time-evolution of in vivo protein corona onto blood-circulating PEGylated liposomal doxorubicin (DOXIL) nanoparticles.
Hadjidemetriou M; Al-Ahmady Z; Kostarelos K
Nanoscale; 2016 Apr; 8(13):6948-57. PubMed ID: 26961355
[TBL] [Abstract][Full Text] [Related]
20. Exploring Cellular Interactions of Liposomes Using Protein Corona Fingerprints and Physicochemical Properties.
Bigdeli A; Palchetti S; Pozzi D; Hormozi-Nezhad MR; Baldelli Bombelli F; Caracciolo G; Mahmoudi M
ACS Nano; 2016 Mar; 10(3):3723-37. PubMed ID: 26882007
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
